Who we are
ABOUT MEDICINES FOR EUROPE
PURPOSE AND OBJECTIVES
OUR VALUES – OUR 5 PILLARS
STRUCTURE
MEMBERS
BECOME A MEMBER
CODE OF CONDUCT
DISCLOSURE
Vacancies
Manifesto 2024
Key topics
ACCESS
INDUSTRIAL POLICY
REGULATORY AND LEGAL FRAMEWORK
FALSIFIED MEDICINES
ENVIRONMENT
ANTIMICROBIAL RESISTANCE
MEDICINE SHORTAGES
COVID-19
Publications
EXTERNAL RESOURCES
FACTSHEETS
INFOGRAPHICS
PODCAST
POLICY
REPORTS
VIDEOS
Newsroom
IN THE NEWS
PRESS RELEASES
Contact us
Login
Generic medicines
Home
Medicines for Europe
Generic medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Biosimilar medicines
Home
Medicines for Europe
Biosimilar medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
DEFINITION
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
External resources
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Value added medicines
Home
Who we are
Value added medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Contact us
Events
Biosimilar Medicines, an Opportunity for Healthcare – Video with subtitles in 15 languages
6 November 2015
Biosimilar medicines, an opportunity for healthcare:
Biosimilar medicines, an opportunity for healthcare (EN subtitles):
Medicamentos biossimilares, uma oportunidade para a Saúde:
Médicaments biosimilaires, une opportunité pour les soins de santé:
Biosimilar-Arzneimittel, eine Chance für die Healthcare:
Medicamentele biosimilare – o oportunitate pentru asistenţa medicală:
Medicamentos biosimilares. Una oportunidad para el sistema de salud:
Leki biopodobne, szansa dla opieki zdrowotnej:
Biosimilární léciva. Príležitost pro zdravotnictví:
Farmaci biosimilari. Un’opportunità
per il settore sanitario:
Biosimilars: een kans voor de gezondheidszorg:
Biosimilære lægemidler.
En mulighed for lægevideskaben:
Biosimilarläkemedel. En möjlighet för sjukvården:
Medicamentos Biossimilares.
Uma oportunidade para a saúde:
Toplum sağlığı için bir fırsat:
Biyobenzer İlaçlar:
Related Posts
Biosimilar Strategy pivotal to a stronger European Health…
18 April 2024
2024 marks the occasion of the 20th annual biosimilar medicines…
Biosimilar medicines critical for future medicines access…
13 December 2023
By 2032, the biosimilar medicines contribution to health systems access…
New IQVIA report points to window of opportunity for the EU…
26 October 2023
The EU is currently reviewing its Pharmaceutical Legislation, and the…
Billions more euros to re-invest in better healthcare thanks…
13 December 2022
Biosimilar medicines deliver access for patients suffering from serious and…
Medicines For Europe
Who we are
Vacancies
Manifesto 2024
Key topics
Publications
Newsroom
Contact us
SECTOR GROUPS
Generic medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Biosimilar medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Value added medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
Events
Share This
LinkedIn
Share on Mastodon
Enter your Mastodon instance URL (optional)
Share
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok